INS and fatty liver disease: Although few studies distinguish pre- versus post-menopausal women, evidence suggest that women at reproductive age are protected against fatty liver disease through estrogen signaling mainly via Estrogen receptors alpha (ERα) to improve liver insulin sensitivity and limit hepatic fat accumulation (25–27).